Concord Biotech Limited (CONCORDBIO.NS)

INR 1733.1

(4.79%)

Operating Expenses Summary of Concord Biotech Limited

  • Concord Biotech Limited's latest annual operating expenses in 2023 was 1.45 Billion INR , up 6.79% from previous year.
  • Concord Biotech Limited's latest quarterly operating expenses in 2024 Q1 was 994.02 Million INR , down -71.1% from previous quarter.
  • Concord Biotech Limited reported a annual operating expenses of 3.83 Billion INR in annual operating expenses 2022, up 30.34% from previous year.
  • Concord Biotech Limited reported a annual operating expenses of 2.94 Billion INR in annual operating expenses 2021, up 63.12% from previous year.
  • Concord Biotech Limited reported a quarterly operating expenses of 1.03 Billion INR for 2023 Q2, up 8.67% from previous quarter.
  • Concord Biotech Limited reported a quarterly operating expenses of 1.09 Billion INR for 2023 Q4, up 8.13% from previous quarter.

Annual Operating Expenses Chart of Concord Biotech Limited (2023 - 2019)

Historical Annual Operating Expenses of Concord Biotech Limited (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 1.45 Billion INR 6.79%
2022 3.83 Billion INR 30.34%
2021 2.94 Billion INR 63.12%
2020 1.8 Billion INR 12.81%
2019 1.59 Billion INR 0.0%

Peer Operating Expenses Comparison of Concord Biotech Limited

Name Operating Expenses Operating Expenses Difference
Biocon Limited 40.9 Billion INR 96.431%
Blue Jet Healthcare Limited 531.85 Million INR -174.458%
Dishman Carbogen Amcis Limited 5.14 Billion INR 71.642%
Jubilant Ingrevia Limited 6.67 Billion INR 78.115%
Lyka Labs Limited 599.4 Million INR -143.525%
Panacea Biotec Limited 1.99 Billion INR 26.847%
Piramal Pharma Limited 19.91 Billion INR 92.67%
SMS Lifesciences India Limited 602.96 Million INR -142.087%
Supriya Lifescience Limited 1.08 Billion INR -35.139%
Syngene International Limited 5.99 Billion INR 75.651%
TAKE Solutions Limited 396.91 Million INR -267.767%
Zota Health Care Limited 457.83 Million INR -218.827%